565
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer

, MD, , MD, , MD & , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bo Ma, Qianqian Ma, Hongqiang Wang, Guolei Zhang, Huiying Zhang & Xiaohong Wang. (2016) Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer. OncoTargets and Therapy 9, pages 959-976.
Read now

Articles from other publishers (4)

Yung-Jue Bang, Toshimi Takano, Chia-Chi Lin, Adedigbo Fasanmade, Huyuan Yang, Hadi Danaee, Takayuki Asato, Thea Kalebic, Hui Wang & Toshihiko Doi. (2018) TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study. Cancer Research and Treatment 50:2, pages 398-404.
Crossref
Maria Letizia Ciavatta, Florence Lefranc, Marianna Carbone, Ernesto Mollo, Margherita Gavagnin, Tania Betancourt, Ramesh Dasari, Alexander Kornienko & Robert Kiss. (2017) Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. Medicinal Research Reviews 37:4, pages 702-801.
Crossref
Ray Bakhtiar. (2016) Antibody drug conjugates. Biotechnology Letters 38:10, pages 1655-1664.
Crossref
Mei Liu, Zhiyang Li, Jingjing Yang, Yanyun Jiang, Zhongsi Chen, Zeeshan Ali, Nongyue He & Zhifei Wang. (2016) Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment. Cell Proliferation 49:4, pages 409-420.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.